Ignite Creation Date:
2025-12-25 @ 1:35 AM
Ignite Modification Date:
2025-12-31 @ 7:36 PM
Study NCT ID:
NCT02977494
Status:
COMPLETED
Last Update Posted:
2022-05-31
First Post:
2016-11-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Daratumumab in Combination With Bortezomib and Dexamethasone in Subjects With Relapsed or Relapsed and Refractory Multiple Myeloma and Severe Renal Impairment
Sponsor:
Universitätsklinikum Hamburg-Eppendorf
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-06
Start Date Type:
ACTUAL
Primary Completion Date:
2021-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-06
Completion Date Type:
ACTUAL
First Submit Date:
2016-11-17
First Submit QC Date:
None
Study First Post Date:
2016-11-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-05-27
Last Update Post Date:
2022-05-31
Last Update Post Date Type:
ACTUAL